Lyrica New Capsule 75mg (Pregabalin)

Adult dose

This medication should be administered orally divided into two doses daily, regardless of meals. For peripheral neuropathic pain, the starting dose is 150 mg daily, with a potential increase to 300 mg daily within 3 to 7 days. If necessary, it can be increased to a maximum of 600 mg daily at 7-day intervals. For central neuropathic pain, the starting dose is also 150 mg daily, and it can be increased to 300 mg daily after one week.

Child dose

For children under 12 years and adolescents aged 12 to 17, safety and efficacy data are insufficient, thus administration is not recommended.

This medication may increase the risk of suicidal thoughts or behavior, so depressive symptoms, mood changes, and unusual behavior should be closely monitored during treatment. Patients with hypersensitivity to this medication or genetic issues such as lactose intolerance should not take it. Diabetic patients need to be cautious about blood sugar control due to weight gain, and should discontinue use immediately if symptoms of angioedema occur. Elderly patients should be careful of the risk of falls due to dizziness or drowsiness, and any occurrences of blurred vision or changes in eyesight should be discussed with a doctor. Suddenly stopping this medication can lead to withdrawal symptoms such as insomnia, headaches, and anxiety, so it should be tapered gradually according to a doctor’s instructions. Due to the risk of drug abuse, patients with a history of substance abuse should be particularly cautious and report any signs of misuse immediately. Patients with heart disease or decreased kidney function should use this medication with caution, and dose adjustments may be necessary. Caution is advised when taking this medication with opioid analgesics due to the risk of central nervous system depression, and respiratory depression symptoms may occur, particularly in the elderly or those with kidney disease. During early pregnancy, there may be a risk of congenital malformations in the fetus, so pregnant women are advised not to take this medication, and fertile women should use effective contraceptive methods. During breastfeeding, as this medication may be passed into breast milk, discussions with a doctor are necessary to determine whether to continue breastfeeding or stop the medication. Before engaging in potentially dangerous activities such as driving or operating machinery, ascertain whether you are experiencing dizziness or drowsiness, and refrain from such activities if present. In rare cases, serious skin reactions may occur while taking this medication; if skin rashes, swelling, or fever develop, discontinue use immediately and consult medical personnel. In the event of an overdose, symptoms such as drowsiness, confusion, depression, and seizures may occur, necessitating immediate medical attention.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, shortness of breath or difficulty breathing, asthma attack, abnormal breathing accompanied by cough + fever, jaundice (yellowing of skin or eyes), severe lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, vision abnormalities, paralysis, urination problems.

Mild side effects

• Dizziness
• drowsiness
• confusion
• disorientation
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly closed container to prevent exposure to air or moisture, at room temperature between 15 to 30 degrees Celsius. Proper storage helps maintain the medication’s effectiveness and prevents degradation.

Appearance

A hard capsule with a brownish-red upper part and a white lower part containing a white to light yellow powder.

Package unit

30 capsules per bottle